RT Journal Article
SR Electronic
T1 Disruption of spatiotemporal clustering in dengue cases by <em>w</em>Mel <em>Wolbachia</em> in Yogyakarta, Indonesia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.24.21261920
DO 10.1101/2021.08.24.21261920
A1 Dufault, Suzanne M.
A1 Tanamas, Stephanie K.
A1 Indriani, Citra
A1 Utarini, Adi
A1 Ahmad, Riris Andono
A1 Jewell, Nicholas P.
A1 Simmons, Cameron P.
A1 Anders, Katherine L.
YR 2022
UL http://medrxiv.org/content/early/2022/03/25/2021.08.24.21261920.abstract
AB Dengue exhibits focal clustering in households and neighborhoods, driven by local mosquito population dynamics, human population immunity, and fine scale human and mosquito movement. We tested the hypothesis that spatiotemporal clustering of homotypic dengue cases is disrupted by introduction of the arbovirus-blocking bacterium Wolbachia (wMel-strain) into the Aedes aegypti mosquito population. We analysed 318 serotyped and geolocated dengue cases (and 5,921 test-negative controls) from a randomized controlled trial in Yogyakarta, Indonesia of wMel deployments. We find evidence of spatial clustering up to 300m among the 265 dengue cases (3,083 controls) in the untreated trial arm. Participant pairs enrolled within 30 days and 50m had a 4.7-fold increase (compared to 95% CI on permutation-based null distribution: 0.1, 1.2) in the odds of being homotypic (i.e. potentially transmission-related) as compared to pairs occurring at any distance. In contrast, we find no evidence of spatiotemporal clustering among the 53 dengue cases (2,838 controls) resident in the wMel-treated arm. Introgression of wMel Wolbachia into Aedes aegypti mosquito populations interrupts focal dengue virus transmission leading to reduced case incidence; the true intervention effect may be greater than the 77% efficacy measured in the primary analysis of the Yogyakarta trial.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT03055585Clinical Protocols https://clinicaltrials.gov/ct2/show/NCT03055585 Funding StatementWe gratefully acknowledge the Tahija Foundation as funders of the AWED trial, and the Wellcome Trust and the Bill and Melinda Gates Foundation, which provided financial support to the World Mosquito Program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The trial protocol for the Applying Wolbachia to Eliminate Dengue (AWED) trial study was approved by the Universitas Gadjah Mada (UGM) ethics committee (approval number KE/FK/105/EC/2016) and Monash University Human Research Ethics Committee (approval number 0960). Written informed consent was obtained from participants (or their guardian where the participant is a minor). In addition, participants between 13 and 17 years of age were invited to sign a consent form indicating that they understood the research and agreed to participate.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesParticipants' residential address was collected and stored under the ethical approval of the AWED trial protocol. Because the geolocated residence is considered personally identifiable information, individuals seeking access to this data should contact Katherine Anders (katherine.anders@monash.edu) to discuss obtaining ethical approval or accessing a deidentified version of the dataset. All analyses were performed with R and the analytical code can be found on GitHub (https://github.com/sdufault15/awed-spatial-temporal). https://github.com/sdufault15/awed-spatial-temporal